세계의 내시경 역행 췌담관 조영술 시장 : 제품, 절차, 최종 사용자별 예측(2025-2030년)

The Endoscopic Retrograde Cholangiopancreatography Market was valued at USD 1.91 billion in 2023, expected to reach USD 2.05 billion in 2024, and is projected to grow at a CAGR of 7.59%, to USD 3.20 billion by 2030.

Endoscopic Retrograde Cholangiopancreatography (ERCP) is a specialized technique combining endoscopy and fluoroscopy to diagnose and treat conditions of the biliary or pancreatic ductal systems. The procedure is particularly necessary for conditions like gallstones, strictures, cysts, cancer, and other blockages, making it indispensable in gastroenterology. ERCP is applied predominantly within hospitals and specialized clinics, serving patients who require comprehensive digestive system evaluations. Amidst the increasing prevalence of pancreatic and biliary diseases, the market is influenced by an aging population and growing awareness about early diagnosis and treatment options. Technological advancements, such as the development of minimally invasive techniques and enhanced imaging solutions, drive significant growth. Moreover, emerging markets in Asia and Latin America present substantial opportunities due to improving healthcare infrastructure and expanding medical tourism. However, the market encounters limitations such as high costs, the need for skilled professionals, and the risk of complications like pancreatitis post-procedure, which might deter its adoption. Challenges include stringent regulatory environments and reimbursement issues in various regions. To capitalize on market opportunities, businesses should focus on innovations in equipment miniaturization, development of more accurate diagnostic procedures, and collaborations with healthcare providers to improve procedural safety and efficacy. Moreover, fostering educational programs to enhance practitioner skills can broaden the adoption of ERCP. The market tends towards competitive consolidation, with strategic alliances and mergers becoming more frequent for firms aiming to expand their technology portfolios and geographic presence. Innovations in artificial intelligence and machine learning could further personalize diagnosis and treatment, making this a promising area for research. Overall, the ERCP market is poised for growth, provided stakeholders navigate barriers effectively and leverage cutting-edge innovations in medical technology and procedural practices.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endoscopic Retrograde Cholangiopancreatography Market

The Endoscopic Retrograde Cholangiopancreatography Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of gastrointestinal and chronic biliary disorders
  • Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
  • Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
• Market Restraints
  • High costs associated with endoscopic retrograde cholangiopancreatography devices
• Market Opportunities
  • Significant research and development activities with heavy investments for advancement of endoscopic procedures
  • Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
• Market Challenges
  • Scarcity of skilled professionals and trained endoscopists across the globe

Porter's Five Forces: A Strategic Tool for Navigating the Endoscopic Retrograde Cholangiopancreatography Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endoscopic Retrograde Cholangiopancreatography Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endoscopic Retrograde Cholangiopancreatography Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endoscopic Retrograde Cholangiopancreatography Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endoscopic Retrograde Cholangiopancreatography Market

A detailed market share analysis in the Endoscopic Retrograde Cholangiopancreatography Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endoscopic Retrograde Cholangiopancreatography Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endoscopic Retrograde Cholangiopancreatography Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endoscopic Retrograde Cholangiopancreatography Market

A strategic analysis of the Endoscopic Retrograde Cholangiopancreatography Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endoscopic Retrograde Cholangiopancreatography Market, highlighting leading vendors and their innovative profiles. These include B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, Machida Endoscope Co., Ltd, Medi-Globe GmbH, Medtronic PLC, Merit Medical Systems, Inc., Olympus Corporation, Ottomed Endoscopy, PENTAX Medical, Richard Wolf GmbH, Smith & Nephew PLC, STERIS, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Endoscopic Retrograde Cholangiopancreatography Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Endoscopes, Endotherapy Devices, Energy Devices, and Visualization Systems. The Endotherapy Devices is further studied across Balloons, Baskets, Cannulas, Catheters, Forceps, Guiding Wires, Lithotripter, Snares, Sphincterotomes, and Stents.
• Based on Procedure, market is studied across Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Dilatation, Pancreatic Duct Stenting, and Pancreatic Sphincterotomy.
• Based on End-User, market is studied across Ambulatory Surgery Centres & Clinics and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of gastrointestinal and chronic biliary disorders
    • 5.1.1.2. Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
    • 5.1.1.3. Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with endoscopic retrograde cholangiopancreatography devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant research and development activities with heavy investments for advancement of endoscopic procedures
    • 5.1.3.2. Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of skilled professionals and trained endoscopists across the globe
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Endoscopic Retrograde Cholangiopancreatography Market, by Product

• 6.1. Introduction
• 6.2. Endoscopes
• 6.3. Endotherapy Devices
  • 6.3.1. Balloons
  • 6.3.2. Baskets
  • 6.3.3. Cannulas
  • 6.3.4. Catheters
  • 6.3.5. Forceps
  • 6.3.6. Guiding Wires
  • 6.3.7. Lithotripter
  • 6.3.8. Snares
  • 6.3.9. Sphincterotomes
  • 6.3.10. Stents
• 6.4. Energy Devices
• 6.5. Visualization Systems

7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure

• 7.1. Introduction
• 7.2. Biliary Dilatation
• 7.3. Biliary Sphincterotomy
• 7.4. Biliary Stenting
• 7.5. Pancreatic Duct Dilatation
• 7.6. Pancreatic Duct Stenting
• 7.7. Pancreatic Sphincterotomy

8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centres & Clinics
• 8.3. Hospitals

9. Americas Endoscopic Retrograde Cholangiopancreatography Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun Melsungen AG
• 2. Becton, Dickinson and Company
• 3. Boston Scientific Corporation
• 4. CONMED Corporation
• 5. Cook Group Incorporated
• 6. Fujifilm Holdings Corporation
• 7. Johnson & Johnson Services, Inc.
• 8. KARL STORZ SE & Co. KG
• 9. Machida Endoscope Co., Ltd
• 10. Medi-Globe GmbH
• 11. Medtronic PLC
• 12. Merit Medical Systems, Inc.
• 13. Olympus Corporation
• 14. Ottomed Endoscopy
• 15. PENTAX Medical
• 16. Richard Wolf GmbH
• 17. Smith & Nephew PLC
• 18. STERIS
• 19. Stryker Corporation